A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Magnetic resonance imaging negative myelopathy in Leber’s hereditary optic neuropathy: a case report




TekijätMartikainen Mika H., Suomela Miika, Majamaa Kari

KustantajaBioMed Central Ltd

Julkaisuvuosi2022

JournalBMC Neurology

Tietokannassa oleva lehden nimiBMC Neurology

Vuosikerta22

Numero1

ISSN1471-2377

DOIhttps://doi.org/10.1186/s12883-022-03007-3

Verkko-osoitehttps://bmcneurol.biomedcentral.com/articles/10.1186/s12883-022-03007-3

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/178410209


Tiivistelmä

Background
Leber’s hereditary optic neuropathy (LHON) is a common form of mitochondrial disease. The typical clinical presentation of LHON is subacute, painless loss of vision resulting from bilateral optic nerve atrophy. Moreover, extra-ocular manifestations such as cardiac conduction abnormalities and neurological manifestations such as multiple sclerosis (MS) like disease or parkinsonism are encountered in some patients. Abnormal findings in spinal cord MR imaging or in the cerebrospinal fluid (CSF) have been observed in previous cases of LHON-associated myelopathy.

Case presentation
We report a male patient with LHON who developed symptoms of myelopathy including gait unsteadiness, enhanced deep tendon reflexes and sensory loss of the lower extremities. Imaging of the brain and spinal cord, CSF analysis, as well as neurography and electromyography did not disclose any abnormalities. The somatosensory evoked potential (SEP) findings were suggestive of dorsal column dysfunction.

Conclusions
The patient case demonstrates that myelopathy associated with LHON can present without abnormal findings in central nervous system MR imaging or in the CSF, and without evidence suggestive of multiple sclerosis or MS-like disease. The dorsal column seems to be particularly vulnerable to myelopathy changes in LHON. Evoked potential investigations may assist in confirming the diagnosis, when clinical features are in line with myelopathy but findings in CSF analysis and central nervous system imaging are normal.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 13:41